摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

trans chlordane | 5103-74-2

中文名称
——
中文别名
——
英文名称
trans chlordane
英文别名
γ-chlordane;trans-Chlordan;(1S,2S,3R,4R,6S,7R)-1,3,4,7,8,9,10,10-octachlorotricyclo[5.2.1.02,6]dec-8-ene
trans chlordane化学式
CAS
5103-74-2
化学式
C10H6Cl8
mdl
——
分子量
409.782
InChiKey
BIWJNBZANLAXMG-GPTKHRSPSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    106°C (estimate)
  • 沸点:
    492.46°C (rough estimate)
  • 密度:
    1.80
  • 闪点:
    -18 °C
  • 溶解度:
    与脂肪族和芳香族溶剂混溶(USEPA,1985)
  • 蒸汽压力:
    2.05e-05 mmHg
  • 亨利常数:
    2.93e-04 atm-m3/mole

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    18
  • 可旋转键数:
    0
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.8
  • 拓扑面积:
    0
  • 氢给体数:
    0
  • 氢受体数:
    0

ADMET

毒理性
  • 副作用
职业性肝毒素 - 第二类肝毒素:在职业环境中的毒性效应潜力是基于人类摄入或动物实验的中毒案例。 其他毒物 - 有机 国际癌症研究机构致癌物 - 第3类:这些化学物质无法被国际癌症研究机构分类。
Occupational hepatotoxin - Secondary hepatotoxins: the potential for toxic effect in the occupational setting is based on cases of poisoning by human ingestion or animal experimentation. Other Poison - Organochlorine IARC Carcinogen - Class 3: Chemicals are not classifiable by the International Agency for Research on Cancer.
来源:Haz-Map, Information on Hazardous Chemicals and Occupational Diseases

安全信息

  • 危险等级:
    6.1(b)
  • 危险品标志:
    F,N,Xn
  • 安全说明:
    S16,S25,S26,S29,S33,S36/37,S45,S60,S61,S62,S9
  • 危险类别码:
    R11,R67,R22,R51/53,R48/20,R65,R40,R48,R62,R36/37/38,R38,R50/53,R20/21/22
  • WGK Germany:
    3
  • RTECS号:
    PC0365000
  • 包装等级:
    III
  • 危险类别:
    6.1(b)

制备方法与用途

类别:农药
毒性分级:高毒
急性毒性:口服-大鼠 LD50: 1100 毫克/公斤;口服-小鼠 LD50: 275 毫克/公斤
可燃性危险特性:热分解排出有毒化物和烟雾
储运特性:库房应低温、通风干燥,并与食品原料分开存放
灭火剂:二氧化碳、泡沫、干粉

文献信息

  • FMO3 inhibitors for treating pain
    申请人:Akron Molecules GmbH
    公开号:EP2674161A1
    公开(公告)日:2013-12-18
    The present invention relates to new therapies to treat pain and related diseases, as well as pharmaceutical compounds for use in said therapies.
    本发明涉及治疗疼痛和相关疾病的新疗法,以及用于上述疗法的药物化合物。
  • Label-free method for the detection of analytes
    申请人:Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V.
    公开号:EP2752664A1
    公开(公告)日:2014-07-09
    The present invention relates to method for the detection and/or characterization of an analyte based on determining and preferably optical determining the alteration of mechanical deformation of hydrogel particles and kits suitable for this method.
    本发明涉及基于测定(最好是光学测定)凝胶颗粒机械变形的变化来检测和/或表征分析物的方法,以及适用于该方法的试剂盒。
  • Membrane-based processes for selectively fractionating essential oils
    申请人:Evonik Membrane Extraction Technology Ltd.
    公开号:US10202562B2
    公开(公告)日:2019-02-12
    The present disclosure in general relates to a process for (1) reducing impurities, i.e. undesirable natural components such as waxes and undesirable synthetic materials such as agrochemicals and other environmental pollutants, or (2) fractionation of natural components present in an essential oil using at least one selective membrane.
    本公开内容总体上涉及一种工艺,用于 (1) 减少杂质,即减少蜡等不良天然成分和农用化学品及其他环境污染物等不良合成材料,或 (2) 使用至少一种选择性膜对精油中的天然成分进行分馏。
  • Compositions and methods for analytical sample preparation
    申请人:Agilent Technologies, Inc.
    公开号:US10564076B2
    公开(公告)日:2020-02-18
    Aspects of the present disclosure include a system for analytical sample preparation. In some embodiments, the system includes a container having disposed therein an analytical sample treatment composition including α-cyclodextrin and/or an α-cyclodextrin co-polymer. Also provided is a method of reducing matrix effects in an analytical sample. In some embodiments, the method includes: contacting a sample including a matrix-interfering agent and an analyte with a cyclodextrin composition to produce a matrix-cyclodextrin complex, wherein the cyclodextrin composition comprises an α-cyclodextrin and/or an α-cyclodextrin co-polymer; separating the complex from the contacted sample to produce a matrix-reduced composition; and detecting the analyte in the matrix-reduced composition. Kits and compositions for use in the subject systems and methods are also provided.
    本公开的各个方面包括一种用于分析样品制备的系统。在某些实施方案中,该系统包括一个容器,容器中放置了分析样品处理组合物,该组合物包括α-环糊精和/或α-环糊精共聚物。还提供了一种减少分析样品中基质效应的方法。在一些实施方案中,该方法包括:将包括基质干扰剂和分析物的样品与环糊精组合物接触,以产生基质-环糊精复合物,其中环糊精组合物包括α-环糊精和/或α-环糊精共聚物;将复合物与接触的样品分离,以产生基质还原组合物;以及检测基质还原组合物中的分析物。此外,还提供了用于所述系统和方法的试剂盒和组合物。
  • Mass spectrometry method, mass spectrometry device, program, and mass spectrometry kit
    申请人:SHIMADZU CORPORATION
    公开号:US11177120B2
    公开(公告)日:2021-11-16
    A mass spectrometry method includes: preparing calibration data for performing calibration on a basis of first data obtained by detecting a chlorobiphenyl in first mass spectrometry of a reference sample of the chlorobiphenyl; acquiring second data obtained by detecting, in second mass spectrometry of a sample, at least one chlorobiphenyl that has a same chlorine number as and is different in kind from the chlorobiphenyl detected in the first mass spectrometry; and calculating a quantitative value for the chlorobiphenyl contained in the sample on a basis of the calibration data and the second data.
    一种质谱分析方法包括:根据在对联苯参考样品的第一次质谱分析中检测联苯而获得的第一次数据,准备用于执行校准的校准数据;获取通过在对样品的第二次质谱分析中检测至少一种联苯而获得的第二次数据,这种联苯数与第一次质谱分析中检测到的联苯相同,但种类不同;以及根据校准数据和第二次数据计算样品中所含联苯的定量值。
查看更多